Burroughs Wellcome & Co. was one of the most influential pharmaceutical companies of the late nineteenth century and the early twentieth, and the largest manufacturer of pharmaceuticals in Britain before the Second World War. Roy Church and E. M. Tansey have produced a detailed and comprehensive account of the complicated history of the business through this period. The book's first part, consisting of eight chapters, outlines the early years of the company, from its establishment in London in 1878 by the hot-headed American pharmacist Silas Burroughs to the successful position it enjoyed by 1914. Topics addressed along the way include the often tumultuous relationship between Burroughs and his partner from 1880, Henry Wellcome; their management of the business; and company expansion, aided by new machines that allowed the standardization of medicines, the use of innovative advertising techniques such as ‘detailing’ medical men, the cultivation of overseas markets and the advance of scientific research in purpose-built laboratories – the first ones of their size in Britain. In the book's second part, also consisting of eight chapters, Church and Tansey consider the impact that the First World War had on production, the development of pharmaceuticals after 1918 and the ultimate decline of the company by 1940. In the final three chapters they reflect further on that decline and the themes and perspectives discussed previously.
The book is not, however, simply a ‘company history’. As its foreword makes clear, the analysis goes far beyond that. The authors locate their story within the context of national and international trade during what they describe as an ‘auspicious period’ in Britain. They also relate it to the wider medical context, including medical professionalization and large-scale immunization and vaccination campaigns, in order to show, in several ways, how (in the words of their subtitle) ‘knowledge, trust and profit’ were involved in transforming the British pharmaceutical industry. Knowledge gained through scientific experiment in the Wellcome laboratories helped shift that industry from the small-scale manufacture of plant-based products to the mass manufacture of synthetic drugs. Obtaining the trust of the medical profession – through advertising and tried-and-tested quality products – and generating profits were ongoing aims. But, as Church and Tansey show, the pursuit of these different aims was often contradictory. Profit was often sacrificed for the more long-term objective of creating trust amongst the medical profession, and tensions existed between scientific research and the laboratories' perceived association with the commercial interests of the company.
The chapters' thematic structure, aided by an impressive amount of new evidence largely from the Wellcome Foundation Archive and Wellcome Archives, means that Church and Tansey's main thesis is very clear and convincing. Furthermore, analysis of this new material has led to the reinterpretation of the history of the company and its founders. Church and Tansey argue that Burroughs played a far more important role than Wellcome's biographers have tended to credit. It was Burroughs who introduced the medical chest into the company's product range and also pioneered the use of detail men as company representatives during the early years of the company. Church and Tansey also suggest that previous studies have greatly exaggerated the extent of the ultimate failure of the firm. Their main conclusion is that trust between the firm and consumers before 1914 was crucial to the company's success, and that a lack of trust between employees played a large part in the failure of the company by 1940.
This book will naturally appeal to business historians and historians of medicine, but it has a much wider remit. There is much of interest for the historian of science, given the company's role in the development of laboratories for the scientific testing of pharmaceuticals and the promotion of biomedical research. Of particular note is Henry Wellcome's 1901 success in achieving registration for the laboratories under the 1876 Cruelty to Animals Act, which the authors consider to be the single most important factor in promoting innovative research within the company. Registration allowed the development of insulin, vitamins and synthetic drugs through physiological research, which paved the way for other British pharmaceutical companies. The employment of only the most dedicated scientists in the research laboratories meant that these men were at the forefront of medical research, seventeen out of twenty-eight becoming Fellows of the Royal Society. The emphasis in all the company's advertising literature on the ‘scientific’ character of its production processes and products, and the frequent allusions to modernity, are also worth noting.
Unquestionably this book documents the pre-eminence of the company in medical research and development in Britain. Given the inclusion of some illuminating illustrations and pictures of advertisements, some further commentary on the associated imagery, language and meanings would have been useful, as would more details on the wider context of advertising in Britain during the period. And though it would have been somewhat outside the scope of the study, a more detailed analysis of the corporate culture, marketing and personnel of UK and international competitors would also have been welcome – for instance, with a more in-depth discussion of how other companies viewed the detailing of medical men. But with the vast potential of the Wellcome Foundation Archive now beginning to be realized, and the archives of other pharmaceutical companies now opening, this impressive book marks a distinguished inaugural foray.
